I was told that a career ending surgery was my only option for my chronic ankle and foot injury, After just 2.5 months on TAVO BPC-157 I was pain free and dancing again.
Heal, repair, improve on a cellular level.
Promotes Healing of Liver
Repairs
Brain Tissue
Supports Gut Health
Repairs
Soft Tissue
Repairs
Bone Tissue
Potent Anti Inflammatory
BPC-157
- Minori Sakita | Professional Ballet Dancer
x
EVERYTHING YOU NEED, NOTHING YOU DON'T.
No Chemicals, No Heavy Metals, No Pesticides, No Fillers,
No Artificial Colors, No Artificial Flavors, No Unnecessary Crap.
What is BPC-157 Peptide(Body Protection Compound 157)
BPC-157 (Body Protection Compound-157) is a peptide derived from a protective protein found naturally in the stomach. It has gained attention for its powerful regenerative properties and its ability to support healing throughout the body. Research suggests BPC-157 may help accelerate the repair of muscles, tendons, ligaments, and even the gut lining. It works by promoting blood flow to damaged tissues, reducing inflammation, and encouraging cellular repair. Because of its wide-ranging benefits and strong safety profile, BPC-157 is increasingly used as a tool for recovery, performance, and overall wellness.
GET BACK TO LIFE
At TAVO Health, our mission is to empower individuals on their journey to optimal well-being. We believe that true healing comes from within, and our commitment is to provide you with high-quality peptides crafted with care and backed by science.
We third party test our supplements for quality and purity to ensure you are getting the most beneficial product on the market.
Benefits of BPC-157 Include:
- Potent anti-inflammatory*
- Possesses neuro-protective properties, specifically modulating the serotonergic and dopaminergic systems*
- Promotes angiogenesis and vasculogenesis*
- Accelerates wound healing (e.g. muscle, ligament, tendon, nerve)*
- Promotes cell survival under stress*
- Maintains GI mucosal integrity*
- Protects and prevents gastric ulcers*
- Improves digestive function (IBS)*
- Used in Inflammatory bowel disease (IBD) exacerbations/flares*
- Protects liver from toxic insults (alcohol, antibiotics, etc) and promotes healing*
- Repairs tissue; such as GIT, tendons, ligaments, brain, bone, etc*
- Effective treatment for Traumatic brain injury (TBI)*
- Protects and heals inflamed intestinal epithelium (Leaky Gut Syndrome)*
BPC-157 Acetate vs. Arginate
What’s the Difference?
BPC-157 is available in different salt forms, with acetate and arginate being the most common. While both contain the same active peptide, the difference lies in how the body absorbs them. BPC-157 arginate is specifically formulated to enhance oral bioavailability, making it far more effective when taken by mouth. The arginate version is better protected against stomach acid and is absorbed more efficiently into the bloodstream, delivering greater systemic benefits compared to the acetate form.
At TAVO Health, we exclusively manufacture using the arginate form of BPC-157 to ensure optimal absorption and effectiveness. This commitment to quality helps deliver the full therapeutic potential of BPC-157 in a convenient oral format.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
LIVE PAIN FREE.
Embrace the transformative capabilities of BPC-157 peptide and unlock the full potential of your body's healing mechanisms.
How Does BPC-157 Facilitate Hard and Soft Tissue Healing?
Tendon and ligament injuries pose challenges due to limited blood supply, hindering effective healing. BPC-157 demonstrates positive effects on tendon, ligament, and bone injuries in animal models. It enhances the production of growth factors such as basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), and VEGF, which guide cells to the site of injury, accelerating the healing process[5].
Additionally, BPC-157 increases the number of growth hormone (GH) receptors in tendons. This action enables targeted GH action at the injured tendon, without elevating GH levels throughout the body, leading to enhanced musculoskeletal development and immune function[6].
- Cell Survival and BPC-157
In vitro experiments show that fibroblasts survive for longer in the presence of BPC-157. Fibroblasts survive about 1.5 times longer when BPC-157 is present[6]. Those cells also tend to be healthier and more active, in turn more capable of carrying out their repair roles.
- Fibroblast Outgrowth and Migration
Fibroblasts are motile cells found in most connective tissue (bones, tendons, muscle, gastric mucosa, skin, etc.). When damage to tissue occurs, fibroblasts migrate to the site of injury in order to start the repair process. They also divide and reproduce to increase the number of fibroblasts available for tissue repair.
In vitro studies show that migration of fibroblasts is directly affected by the amount of BPC-157 present. Where higher levels of BPC-157 are found, higher amounts of fibroblasts can also be found.
Evidence shows that BPC-157 doesn’t just attract, but that it actually causes fibroblasts to migrate nearly 2.5 times faster than normal. Not only do the cells migrate in response to BPC-157 levels, they reproduce in response to them as well. Fibroblast outgrowth is approximately three times higher in the presence of BPC-157[13].
- Fibroblasts and Genetic Modification
Animal test studies show that BPC-157 controls the functions of collagen fragments by promoting the work of fibroblasts, the cells responsible for collagen deposition and maintenance. These studies have revealed that BPC-157 influences fibroblasts by upregulating expression of the GH receptor gene. In other words BPC-157 alters the function of DNA.
Fibroblasts are found all throughout the body, and are especially active in connective tissue. BPC-157 boosts the GH response by increasing GH receptor density to the injured connective tissue. The result is that even with normal physiologic levels of GH, more is recruited to the site of injury causing healing to proceed at a faster rate. Ongoing testing and research is revealing more and more beneficial effects of BPC-157.
How Does BPC-157 Promote Blood Vessel Function?
Studies reveal that BPC-157 operates through two distinct mechanisms within blood vessels. Firstly, it aids in vasodilation, facilitating smoother blood flow, by elevating the levels of nitric oxide, a natural compound. Nitric oxide not only helps regulate blood pressure but also maintains the health of endothelial cells that line blood vessels.
Secondly, BPC-157 directly stimulates the growth of endothelial cells, thereby promoting blood vessel formation[1],[2]. It achieves this by increasing nitric oxide production within blood vessels and activating the vascular endothelial growth factor (VEGF), a growth factor that triggers endothelial cell division and growth. These findings suggest that BPC-157 induces favorable alterations in DNA expression patterns, supporting blood vessel growth and overall vascular health.
How Does BPC-157 Aid in Wound Repair?
BPC-157 accelerates wound healing by restoring blood flow to damaged tissues. This effect is observed in various tissues such as the stomach, heart, tendons, and skin. The peptide enhances blood vessel growth towards the site of injury, increasing blood circulation. Additionally, BPC-157 stimulates the migration of fibroblasts, cells responsible for generating the extracellular matrix crucial for initiating wound healing.
The peptide's ability to expedite wound repair is exemplified by its effectiveness in healing fistulas, which are notoriously difficult to treat. While traditional methods may take over two and a half years, BPC-157 achieves healing within a month in animal models[1],[3],[4].
Synergistic effects of BPC-157 and TB4 Fragment(Ac-SDKP)
The benefits of TB4 frag and BPC-157 generally arise from the fact that these two peptides affect the same cells in slightly different ways. TB4 frag boost cell migration and cell motility, this may sound trivial, but the ability of cells like fibroblasts to get to sites of injury is a rate limiting step in tissue repair. Many of these cells die before they reach their destination or simply don’t last long once they get there, so boosting their ability to move around is of massive benefit. Combining the ability of cells to get to the site of injury with an ability to function better and for longer once they are there is a triple synergy. This is where BPC-157 builds on the benefits of TB4 frag. BPC-157 improves fibroblast cell function by increasing growth hormone receptor density, thus improving both the longevity of these cells and their ability to grow/divide during the healing process. The result is that more cells get to the site of tissue injury and they are healthy when they get there. Healthy cells not only do more work, they produce more offspring that can then also do more work. This is why combining TB4 frag with BPC-157 is likely not just an additive process, but a multiplicative process. The benefits build on one another to dramatically increase tissue repair following injury.
Synergy in Neurological Recovery
TB4 frag has been shown in animal models to encourage the growth and proliferation of both central and peripheral nervous system tissues following injury. It is thought that TB4 activates the cells that support neurons, allowing them to provide more nutrients to the damaged cells as they recover[C]. These studies have shown that TB4 administration leads to substantial improvements in behavior, motor control and cognitive impairment[D].
Research also indicates that TB4 frag can help to reduce oxidative stress and improve the recovery of neural stem cells. BPC-157 may play a similar role in the brain as research has shown that it protects somatosensory neurons from injury by reducing inflammation in the nervous system[E]. BPC-157 also plays a protective role in the central nervous system, helping it to prepare for damage before it happens. It isn’t clear how it achieves this function specifically, but it does play an important role in signaling from the GI system. Researchers think that it may act as an early warning molecule to the brain, letting it know that noxious damage is on the way so that it can prepare. It is believed that BPC-157 helps the brain to maintain homeostasis even in the setting of traumatic injury.
TB4 frag has been tested in animal models of multiple sclerosis and found to help decrease levels of inflammatory molecules in the brain. This results in reversal of demyelination, the hallmark of multiple sclerosis and a marker of disease severity[F]. This benefit is probably mediated by enhanced neural supportive cell migration.
Together, BPC-157 and TB4 frag could substantially impact the health of the nervous system by reducing inflammation and oxidative stress, protecting cells that support neurons, and improving migration of cells that are responsible for tissue repair.
Muscle Recovery and Bone Strength with BPC 157 and TB-4 Fragments(Ac-SDKP)
BPC-157 is an efficient promoter of tendon healing. Tendons are notoriously difficult to repair following injury and generally require surgical intervention to restore full function and range of motion[G]. Research shows that BPC-157 accelerates tendon repair by boosting fibroblast outgrowth and migration. Interestingly, BPC-157 also improves the quality of the repair. BPC-157 not only speeds recovery of injured tendons but it improves the outcome such that the tendon is stronger and more functional than had BPC-157 not been administered[H].
TB4 frag is effective in speeding musculoskeletal recovery both following injury and following exercise. Because it speeds the rate of migration of cells, it would directly impact tendon repair where fibroblast migration has been observed to be slow and incomplete under natural circumstances. The slow migration of immune cells and fibroblasts into tendons is at least in part because of poor blood supply. Both BPC-157 and TB4 frag are angiogenic and accelerate the growth of blood vessels. Together, these peptides can boost blood supply to injured tissue, particularly to tissue like tendons which have inadequate blood supply for healing. This not only speeds recovery by getting repair cells where they need to be, it improves the final outcome by increasing extracellular matrix deposition.
Another way in which BPC-157 and TB4 frag interact to help heal musculoskeletal injuries is boosting growth hormone. Research shows that BPC-157 increases the expression of growth hormone receptors on fibroblasts. Growth hormone is extremely important in musculoskeletal development and repair. BPC-157 circumvents some side effects by boosting receptors rather than the hormone itself[I]. This leads to targeted benefits in tissue repair without as many traditional side effects. So, fibroblasts essentially receive a boost of growth hormone by expressing more receptors, which can lead to their proliferation and increase their longevity. Combined with the motility effects of TB4 frag, BPC-157 can enhance the function of fibroblasts. In other words, not only are there more repair cells to get the work done, the cells that are involved in the repair are more effective. The benefits stack up on one another to potentially supercharge the healing process.
References
[1]T. Huang et al., “Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro,” Drug Des. Devel. Ther., vol. 9, pp. 2485–2499, 2015, doi: 10.2147/DDDT.S82030.
[2]S. A. Deek, “BPC 157 as Potential Treatment for COVID-19,” Med. Hypotheses, vol. 158, p. 110736, Jan. 2022, doi: 10.1016/j.mehy.2021.110736.
[3]P. Sikiric et al., “Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing,” Curr. Pharm. Des., vol. 24, no. 18, pp. 1990–2001, 2018, doi: 10.2174/1381612824666180608101119.
[4]M. Baric et al., “Stable gastric pentadecapeptide BPC 157 heals rectovaginal fistula in rats,” Life Sci., vol. 148, pp. 63–70, Mar. 2016, doi: 10.1016/j.lfs.2016.02.029.
[5]S. Seiwerth et al., “BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing,” Curr. Pharm. Des., vol. 24, no. 18, pp. 1972–1989, 2018, doi: 10.2174/1381612824666180712110447.
[6]C.-H. Chang, W.-C. Tsai, Y.-H. Hsu, and J.-H. S. Pang, “Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts,” Mol. Basel Switz., vol. 19, no. 11, Art. no. 11, Nov. 2014, doi: 10.3390/molecules191119066.
[7]P. Sikiric et al., “Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications,” Curr. Neuropharmacol., vol. 14, no. 8, Art. no. 8, Nov. 2016, doi: 10.2174/1570159X13666160502153022.
[8]P. Sikiric et al., “Stable Gastric Pentadecapeptide BPC 157, Robert’s Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye’s Stress Coping Response: Progress, Achievements, and the Future,” Gut Liver, vol. 14, no. 2, pp. 153–167, Mar. 2020, doi: 10.5009/gnl18490.
[9]S. Radeljak, S. Seiwerth, and P. Sikiric, “BPC 157 inhibits cell growth and VEGF signalling via the MAPK kinase pathway in the human melanoma cell line,” Melanoma Res., vol. 14, pp. A14–A15, Aug. 2004, doi: 10.1097/00008390-200408000-00050.
[10]R. Rucman, “Stable pentadecapeptide salts, a process for preparation thereof, a use thereof in the manufacture of pharmaceutical preparations and a use thereof in therapy,” US9850282B2, Dec. 26, 2017 Accessed: Jul. 23, 2020. [Online]. Available: https://patents.google.com/patent/US9850282B2/en
[11] “Wake Forest University Publishes Mechanism of Action Reseach.” H-Wave, 5 Oct. 2009, www.h-wave.com/blog/wake-forest-university-publishes-moa-reseach/.
[12] “Figure 3 the Physiological Roles of Nitric Oxide on Endothelial Function.” ResearchGate, www.researchgate.net/figure/The-physiological-roles-of-nitric-oxide-on-endothelial-function_fig1_267335644.
[13] T. Cerovecki, I. Bojanic, L. Brcic, B. Radic, I. Vukoja, S. Seiwerth, and P. Sikiric, "Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat," J. Orthop. Res. Off. Publ. Orthop. Res. Soc., vol. 28, no. 9, pp. 1155-1161, Sep. 2010.
[2]S. A. Deek, “BPC 157 as Potential Treatment for COVID-19,” Med. Hypotheses, vol. 158, p. 110736, Jan. 2022, doi: 10.1016/j.mehy.2021.110736.
[3]P. Sikiric et al., “Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing,” Curr. Pharm. Des., vol. 24, no. 18, pp. 1990–2001, 2018, doi: 10.2174/1381612824666180608101119.
[4]M. Baric et al., “Stable gastric pentadecapeptide BPC 157 heals rectovaginal fistula in rats,” Life Sci., vol. 148, pp. 63–70, Mar. 2016, doi: 10.1016/j.lfs.2016.02.029.
[5]S. Seiwerth et al., “BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing,” Curr. Pharm. Des., vol. 24, no. 18, pp. 1972–1989, 2018, doi: 10.2174/1381612824666180712110447.
[6]C.-H. Chang, W.-C. Tsai, Y.-H. Hsu, and J.-H. S. Pang, “Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts,” Mol. Basel Switz., vol. 19, no. 11, Art. no. 11, Nov. 2014, doi: 10.3390/molecules191119066.
[7]P. Sikiric et al., “Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications,” Curr. Neuropharmacol., vol. 14, no. 8, Art. no. 8, Nov. 2016, doi: 10.2174/1570159X13666160502153022.
[8]P. Sikiric et al., “Stable Gastric Pentadecapeptide BPC 157, Robert’s Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye’s Stress Coping Response: Progress, Achievements, and the Future,” Gut Liver, vol. 14, no. 2, pp. 153–167, Mar. 2020, doi: 10.5009/gnl18490.
[9]S. Radeljak, S. Seiwerth, and P. Sikiric, “BPC 157 inhibits cell growth and VEGF signalling via the MAPK kinase pathway in the human melanoma cell line,” Melanoma Res., vol. 14, pp. A14–A15, Aug. 2004, doi: 10.1097/00008390-200408000-00050.
[10]R. Rucman, “Stable pentadecapeptide salts, a process for preparation thereof, a use thereof in the manufacture of pharmaceutical preparations and a use thereof in therapy,” US9850282B2, Dec. 26, 2017 Accessed: Jul. 23, 2020. [Online]. Available: https://patents.google.com/patent/US9850282B2/en
[11] “Wake Forest University Publishes Mechanism of Action Reseach.” H-Wave, 5 Oct. 2009, www.h-wave.com/blog/wake-forest-university-publishes-moa-reseach/.
[12] “Figure 3 the Physiological Roles of Nitric Oxide on Endothelial Function.” ResearchGate, www.researchgate.net/figure/The-physiological-roles-of-nitric-oxide-on-endothelial-function_fig1_267335644.
[13] T. Cerovecki, I. Bojanic, L. Brcic, B. Radic, I. Vukoja, S. Seiwerth, and P. Sikiric, "Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat," J. Orthop. Res. Off. Publ. Orthop. Res. Soc., vol. 28, no. 9, pp. 1155-1161, Sep. 2010.